Fish-oil-derived eicosapentaenoic acid decreases survivin expression and induces wt-p53 accumulation with caspase-3

M R Sam1, M Esmaeillou1, S Sam1

  • 11 Department of Cellular and Molecular Biotechnology, Institute of Biotechnology, Urmia University, Urmia, Iran.

Abstract

Insights

Eicosapentaenoic acid (EPA) effectively targets wild-type p53 and survivin in acute lymphoblastic leukemia (ALL) cells. This study shows EPA induces apoptosis and reduces proliferation, offering a potential therapeutic strategy for resistant ALL.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Dysregulation of wild-type p53 (wt-p53) and survivin is linked to treatment resistance in acute lymphoblastic leukemia (ALL).
  • Currently, no approved drugs effectively modulate wt-p53 and survivin for ALL treatment.
  • Eicosapentaenoic acid (EPA) is investigated for its potential to target these pathways at concentrations found in human plasma.

Purpose of the Study:

  • To investigate the in vitro effects of eicosapentaenoic acid (EPA) on wt-p53 and survivin modulation in ALL cells.
  • To evaluate EPA's impact on cell viability, proliferation, apoptosis, and related molecular markers.

Main Methods:

  • Molt-4 ALL cells (expressing wt-p53) were treated with varying concentrations of EPA (50–200 µM).
  • Evaluated parameters included cell number, viability, proliferation, survivin mRNA and protein expression, wt-p53 accumulation, caspase-3 activation, and apoptosis.
  • Measurements were taken at 48 and 72 hours post-treatment.

Main Results:

  • EPA significantly reduced ALL cell proliferation and metabolic activity in a dose- and time-dependent manner.
  • EPA treatment led to substantial decreases in survivin mRNA and protein levels.
  • EPA induced significant increases in caspase-3 activation and wt-p53 accumulation, enhancing the wt-p53/survivin and caspase-3/survivin ratios.
  • EPA treatment markedly increased apoptosis in ALL cells with minimal necrosis.

Conclusions:

  • Eicosapentaenoic acid (EPA) effectively induces wt-p53 accumulation and significantly downregulates survivin expression in ALL cells.
  • EPA demonstrates potential as a therapeutic agent for modulating wt-p53 and survivin pathways in acute lymphoblastic leukemia.